The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Heart Rhythm. 2012 Feb;9(2):199-208. doi: 10.1016/j.hrthm.2011.09.004. Epub 2011 Sep 9.
Cardiac rhythm devices are important in the management of pediatric patients with rhythm abnormalities, although factors driving utilization are poorly understood.
This study sought to evaluate utilization trends, complication rates, and cost associated with device implantation in the pediatric population.
Device implantation was analyzed using the Kids' Inpatient Database from 1997 to 2006. The type of device implantation, patient demographics, hospital characteristics, acute in-hospital complications, cost, and length of stay (LOS) were analyzed. χ(2) tests were used to test association between categorical variables, and logistic regression analysis was performed to evaluate risk factors associated with complications.
There were 5788 hospitalizations with device implantations. Although there was a significant increase in defibrillator implantation, there was no significant increase in the number of pacemaker implantations over this time period. Patient- and device-related complications were relatively common in all device cohorts (pacemaker 11.2%, 7.2%; defibrillator 5.9%, 11.5%; and biventricular device 19.4%, 26.7%). Type of complication was dependent on device type. Increased risk of complication was evident in the pacemaker cohort, patients with congenital heart disease, cardiomyopathy, previous cardiac arrest, and other heart operations. Patient-related complications increased cost and LOS regardless of patient or procedural characteristics. Device implantation in patients <5 years old was associated with increased LOS and cost but was not associated with increased risk of complication.
Device utilization in pediatrics is increasing due to escalating defibrillator implantation and biventricular pacing. Cost and LOS are significantly increased by patient complications. Reduction in these complications would improve patient care and lower medical costs.
心脏节律装置在管理儿科节律异常患者方面非常重要,尽管其利用的驱动因素尚未被充分理解。
本研究旨在评估儿科人群中心律装置植入的利用趋势、并发症发生率和相关成本。
利用 1997 年至 2006 年的儿科住院患者数据库分析装置植入情况。分析的内容包括装置类型、患者人口统计学特征、医院特征、急性院内并发症、成本和住院时间(LOS)。使用卡方检验比较分类变量之间的关系,采用逻辑回归分析评估与并发症相关的危险因素。
共有 5788 例患者进行了装置植入。尽管除颤器的植入数量显著增加,但同期起搏器的植入数量并没有显著增加。所有装置组中患者和装置相关并发症都相对常见(起搏器 11.2%,7.2%;除颤器 5.9%,11.5%;和双心室装置 19.4%,26.7%)。并发症类型取决于装置类型。在起搏器组中,患有先天性心脏病、心肌病、既往心脏骤停和其他心脏手术的患者并发症风险增加。患者相关并发症增加了成本和 LOS,无论患者或手术特点如何。<5 岁患者的装置植入与 LOS 和成本增加有关,但与并发症风险增加无关。
由于除颤器植入和双心室起搏的增加,儿科装置的利用率不断提高。患者并发症显著增加了成本和 LOS。减少这些并发症将改善患者的护理并降低医疗成本。